The Company is a global provider of solutions that advance the drug discovery and development process. It provides the animal research models required in research and development for new drugs, devices and therapies.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Yes they have taken their lumps, but nonetheless I think they are poised for a strong recovery. They should be profitable next year, and they have a constantly in demand product. I used to think they were a potential buyout target, but apparently major pharma only likes to make stupid deals so that probably wont happen. Nonetheless CRL should run from here